MacroGenics
MGNX
A$2.03
Share price
-4.38%
Change (1 day)
-68.96%
Change (1 year)
Categories
MacroGenics (MGNX) Fails to deliver data
Key failure to deliver metrics for MacroGenics:
- Last SEC data release: 2025-05-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: A$0.02 M
- Last year FTD volume: A$0.02 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for MacroGenics (MGNX) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for MacroGenics (MGNX) - since 2013
Volume in USD (price x number of shares), data since 2013MacroGenics (MGNX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | A$0.02 M | -99.59% |
| 2024 | A$6.51 M | 398.62% |
| 2023 | A$1.3 M | -18.82% |
| 2022 | A$1.6 M | -70.7% |
| 2021 | A$5.49 M | -86.47% |
| 2020 | A$40.6 M | 56.41% |
| 2019 | A$25.96 M | 1465.1% |
| 2018 | A$1.65 M | -73.54% |
| 2017 | A$6.26 M | 85.1% |
| 2016 | A$3.38 M | -55.49% |
| 2015 | A$7.6 M | -35.48% |
| 2014 | A$11.79 M | 65.01% |
| 2013 | A$7.14 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Xencor XNCR | A$0.12 M | A$3.69 M | 🇺🇸 USA |
 Pfizer PFE | A$28.79 M | A$0.35 B | 🇺🇸 USA |
 Merck MRK | A$19.34 M | A$0.18 B | 🇺🇸 USA |
 Gilead Sciences GILD | A$0.16 B | A$0.25 B | 🇺🇸 USA |
 Amgen AMGN | A$82.72 M | A$0.33 B | 🇺🇸 USA |
 Eli Lilly LLY | A$26.07 M | A$0.20 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | A$14.98 M | A$0.27 B | 🇺🇸 USA |